Michael Addition of Stannyl Ketone Enolate
A R T I C L E S
reduced pressure: bp 120 °C/2 mmHg. IR (neat): 1705, 1643 cm-1
236.1025, 263.1044, 236.1051 (M+). Anal. Calcd for C13H16O4: C,
66.09; H, 6.83. Found: C, 66.11; H, 6.80.
.
1H NMR (270 Hz, CDCl3): 3.02 (NMeA, 3H), 2.93 (NMeB, 3H), 2.48-
1.39 (m, 13H). 13C NMR (67.9 Hz, CDCl3): 213.48 (s, cycloCO),
172.87 (s, C-1), 49.99 (d, CH), 42.19 (t), 37.17 (q), 35.24 (q), 34.58
(t), 31.02 (t), 28.10 (t), 25.35 (t), 24.96 (t). MS (EI, 70 eV): m/z 197
(M+, 24), 153 (M+ - NMe2, 4), 125 (M+ - CONMe2, 14), 100 (20),
97 (3), 72 (26). HRMS (EI, 70 eV): calcd for C11H19NO2 197.1416,
found m/z 197.1407, 197.1407 (M+). Anal. Calcd for C11H19NO2: C,
66.97; H, 9.71; N, 7.10. Found: C, 64.96; H, 9.67; N, 6.79.
Tetracarbonyl Compound 3aj. According to the general procedure,
this compound was prepared from 1a and 2j in dry THF to give the
product as a colorless liquid after chromatography (hexane/Et2O, 1/1).
Further purification was performed by distillation under reduced
pressure: bp 220 °C/3.8 × 10-2 mmHg. IR (neat): 1732, 1681 cm-1
.
1H NMR (270 MHz, CDCl3): 7.98-7.93 (m, 4H, aroma), 7.59-7.27
(m, 6H, aroma), 4.23 (t, J ) 4.9 Hz, 4H, 2 × COOCH2), 3.68 (t, J )
4.9 Hz, 4H, 2 × COOCH2CH2), 3.06 (t, J ) 7.3 Hz, 4H, 2 ×
PhCOCH2), 2.47 (t, J ) 7.3 Hz, 4H, 2 × CH2COO), 2.07 (t, J ) 7.3
Hz, 2 × PhCOCH2CH2). 13C NMR (67.9 MHz, CDCl3): 199.32 (s,
PhCO), 173.13 (COO), 136.73 (ipso), 133.03, 128.54, 127.96, 68.99
(OCH2), 63.31 (OCH2), 37.35 (PhCOCH2), 33.16 (OCOCH2), 19.24
(PhCOCH2CH2). MS (CI, 70 eV): m/z 455 (M+ + 1, 3), 335 (49), 235
(6), 219 (9), 147 (6), 105 (18). HRMS (CI, 70 eV): calcd for C26H31O7
455.2070, found m/z 455.2048, 455.2052 (M+ + 1). Anal. Calcd for
C26H30O7: C, 68.71; H, 6.65. Found: C, 69.01; H, 6.66.
N,N-Dimethyl 4-Methyl-5-oxo-5-phenylpentanamide (3dk). Ac-
cording to the general procedure, this compound was prepared from
1d and 2k in dry THF to give the product as a colorless liquid after
chromatography (Et2O). Further purification was performed by distil-
lation under reduced pressure: bp 170 °C/2 mmHg. IR (neat): 1682,
1643 cm-1. 1H NMR (270 MHz, CDCl3): 8.02-7.98 (m, 2H, aroma),
7.59-7.44 (m, 3H, aroma), 3.68 (qt, J ) 6.8, 5.9 Hz, 1H, 4-H), 2.93
(s, 3H, NMeA), 2.92 (s, 3H, NMeB), 2.47-2.08 (m, 3H, 2-H2 and 3-HA),
1.91-1.76 (m, 1H, 3-HB), 1.22 (d, J ) 6.8 Hz, 3H, 4-Me). 13C NMR
(67.9 MHz, CDCl3): 204.14 (C-5), 172.44 (C-1), 136.45 (ipso), 132.96,
128.63, 128.36, 39.75 (C-4), 37.14 (NMeA), 35.33 (NMeB), 30.55 (C-
2), 28.59 (C-3), 17.59 (4-Me). MS (EI, 70 eV): m/z 233 (M+, 14),
189 (M+ - NMe2, 4), 161 (M+ - CONMe2, 10), 128 (19), 105 (100),
77 (33), 72 (56). HRMS (EI, 70 eV): calcd for C14H19NO2 233.1416,
found m/z 233.1401, 233.1395 (M+). Anal. Calcd for C14H19NO2: C,
72.07; H, 8.21; N, 6.00. Found: C, 72.15; H, 8.15; N, 6.00.
N,N-Dimethyl-5-oxo-5-phenylpentanamide (3ak). According to the
general procedure, this compound was prepared from 1a and 2k in dry
THF to give the product as a colorless liquid after chromatography
using [Fuji Silysia FL100DX] (hexane/Et2O, 1/1). Further purification
was performed by distillation under reduced pressure: bp 130 °C/1.5
× 10-1 mmHg. IR (neat): 1682, 1643 cm-1
.
1H NMR (270 MHz,
CDCl3): 8.01-7.96 (m, 2H, aroma), 7.59-7.40 (m, 3H, aroma), 3.11
(t, J ) 6.8 Hz, 2H, 4-H2), 3.01 (s, 3H, NMeA), 2.95 (s, 3H, NMeB),
2.44 (t, J ) 6.8 Hz, 2H, 2-H2), 2.09 (qn, J ) 6.8 Hz, 2H, 3-H2). 13C
NMR (67.9 MHz, CDCl3): 200.14 (C-5), 172.45 (C-1), 136.88 (ipso),
132.99, 128.55, 128.08, 37.76 (C-4), 37.18 (NMeA), 35.33 (NMeB),
32.32 (C-2), 19.62 (C-3). MS (EI, 70 eV): m/z 219 (M+, 26), 175
(M+ - NMe2, 12), 147 (M+ - CONMe2, 32), 105 (100), 77 (41).
HRMS (EI, 70 eV): calcd for C13H17NO2 219.1259, found m/z 219.1255
(M+).
2,2-Dimethyl-3,7-dioxo-5,7-diphenylheptane (3em). According to
the general procedure, this compound was prepared from 1e and 2m
in dry THF to give the product as a colorless liquid after chromatog-
raphy (hexane/Et2O, 2/1). Further purification was performed by
distillation under reduced pressure: bp 175 °C/4.0 × 10-2 mmHg. IR
(neat): 1689 cm-1. 1H NMR (270 MHz, CDCl3): 8.00-7.90 (m, 2H,
aroma), 7.56-7.13 (m, 8H, aroma), 3.91 (qn, J ) 6.8 Hz, 1H, 5-H),
3.38 (dd, J ) 16.1, 6.8 Hz, 1H, 6-HA), 3.26 (dd, J ) 16.1, 7.3 Hz, 1H,
6-HB), 2.93 (d, J ) 6.8 Hz, 2H, 4-H2), 1.04 (s, 9H, CMe3). 13C NMR
(67.9 MHz, CDCl3): 213.85 (C-3), 198.60 (C-7), 143.97 (ipso), 136.84
(ipso), 132.91, 128.46, 128.40, 128.05, 127.41, 126.46, 44.52, 44.03
(C-2), 42.85, 36.65, 26.06 (CMe3). MS (EI, 70 eV): m/z 308 (M+,
1,5-Diphenyl-3-methyl-1,5-pentanedione (3ab). According to the
general procedure, this compound was prepared from 1a and 2b in dry
THF to give the product as a colorless liquid after chromatography
(hexane/Et2O, 5/1). Further purification was performed by distillation
under reduced pressure: bp 165 °C/3.5 × 10-2 mmHg. IR (neat): 1678
cm-1. 1H NMR (270 MHz, CDCl3): 8.02-7.98 (m, 4H, aroma), 7.60-
7.43 (m, 6H, aroma), 3.23-3.13 (m, 2H, 2-HA and 4-HA), 2.93-2.81
(m, 3H, 2-HB, 4-HB, and 3-H), 1.09 (d, J ) 5.9 Hz, 3H, 3-Me). 13C
NMR (67.9 MHz, CDCl3): 199.64 (s, C-1 and C-5), 137.02 (s, ipso),
133.03 (d), 128.59 (d), 128.17 (d), 45.37 (t, C-2 and C-4), 26.62 (d,
C-3), 20.27 (q, 3-Me). MS (EI, 70 eV): m/z 266 (M+, 0.7), 161 (2),
147 (51), 105 (100), 77 (55). HRMS (EI, 70 eV): calcd for C18H18O2
266.1307, found m/z 266.1302 (M+). Anal. Calcd for C18H18O2: C,
81.17; H, 6.81. Found: C, 80.93; H, 6.96.
3-(2-Oxo-2-phenylethyl)cyclohexanone (3al). According to the
general procedure, this compound was prepared from 1a and 2l in dry
THF to give the product as a colorless liquid after chromatography
(hexane/Et2O, 1/1). Further purification was performed by distillation
under reduced pressure: bp 185 °C/2.8 × 10-2 mmHg. IR (neat): 1710,
1680 cm-1. 1H NMR (270 MHz, CDCl3): 7.95-7.92 (m, 2H, aroma),
7.60-7.40 (m, 3H, aroma), 3.04 (dd, J ) 16.1, 6.8 Hz, 1H, PhCOCHA),
2.94 (dd, J ) 16.1, 5.8 Hz, 1H, PhCOCHB), 2.6-1.4 (m, 9H, ring).
13C NMR (67.9 MHz, CDCl3): 210.62 (s, C-1), 198.38 (s, PhCO),
136.96 (s, ipso), 133.22 (d), 128.66 (d), 128.04 (d), 47.77 (t, PhCOCH2),
44.68 (t, C-2), 41.23 (t, C-6), 34.87 (d, C-3), 31.12 (t, C-4), 24.88 (t,
C-5). MS (EI, 70 eV): m/z 216 (M+, 14), 120 (56), 105 (100), 96
(33), 77 (36). HRMS (EI, 70 eV): calcd for C14H16O2 216.1150, found
m/z 216.1161 (M+). Anal. Calcd for C14H16O2: C, 77.75; H, 7.46.
Found: C, 77.58; H, 7.47.
t
t
36), 251 (M+ - Bu, 63), 209 (M+ - BuCOCH2, 34), 189 (58), 131
(100). HRMS (EI, 70 eV): calcd for C21H24O2 308.1776, found m/z
308.1772, 308.1777 (M+). Anal. Calcd for C21H24O2: C, 81.78; H, 7.84.
Found: C, 81.57; H, 7.79.
1-(2-Thienyl)-ethen-1-ol Acetate. bp 34 °C/2 mmHg. IR (neat):
1766, 1635, 1195 cm-1. 1H NMR (270 MHz, CDCl3): 7.26-7.22 (m,
1H, aroma), 7.12-7.09 (m, 1H, aroma), 6.99-6.95 (m, 1H, aroma),
5.38 (d, J ) 2.4 Hz, 1H, 2-HA), 4.94 (d, J ) 2.4 Hz, 1H, 2-HB), 2.27
(s, 3H, COMe). 13C NMR (67.9 MHz, CDCl3): 168.66 (CO), 147.65
(C-1), 138.13, 127.42, 125.77, 124.64, 101.16 (C-2), 20.82 (Me). MS
(EI, 70 eV): m/z 168 (M+, 26), 125 (M+ - OMe, 100), 109 (M+
-
OCOMe, 6), 83 (C4H3S+, 20), 43 (33). HRMS (EI, 70 eV): calcd for
C8H8O2S 168.0245, found m/z 168.0251 (M+).
Computational Method. We applied the HF/DFT hybrid method
originally proposed by Becke,27 referenced as a B3PW91 three-
parameter hybrid functional. All calculations were performed with
Gaussian 98 revision A.7.28 For basis sets, 6-31+G(d) was employed
for H, C, O, and Br atoms, and LanL2DZ was employed for Sn,
(27) Becke, A. D. J. Chem. Phys. 1993, 98, 5648-5652.
(28) Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M.
A.; Cheeseman, J. R.; Zakrzewski, V. G.; Montgomery, J. A., Jr.; Stratmann,
R. E.; Burant, J. C.; Dapprich, S.; Millam, J. M.; Daniels, A. D.; Kudin,
K. N.; Strain, M. C.; Farkas, O.; Tomasi, J.; Barone, V.; Cossi, M.; Cammi,
R.; Mennucci, B.; Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J.;
Petersson, G. A.; Ayala, P. Y.; Cui, Q.; Morokuma, K.; Malick, D. K.;
Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Cioslowski, J.; Ortiz,
J. V.; Baboul, A. G.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.;
Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham,
M. A.; Peng, C. Y.; Nanayakkara, A.; Gonzalez, C.; Challacombe, M.;
Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Andres, J. L.;
Gonzalez, C.; Head-Gordon, M.; Replogle, E. S.; Pople, J. A. Gaussian
98, revision A.7; Gaussian, Inc.: Pittsburgh, PA, 1998.
N,N-Dimethyl 3-(2-Oxocyclohexyl)propanamide (3ck). According
to the general procedure, this compound was prepared from 1c and 2k
in dry THF to give the product as a colorless liquid after chromatog-
raphy (Et2O). Further purification was performed by distillation under
9
J. AM. CHEM. SOC. VOL. 125, NO. 24, 2003 7299